Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)

Market Cap	3.13B -4.6%
Revenue (ttm)	745.31M -15.8%
Net Income	54.34M -36.8%
EPS	0.09 -34.7%
Shares Out	583.03M
PE Ratio	61.75
Forward PE	n/a
Dividend	0.03 (0.45%)
Ex-Dividend Date	Jun 17, 2025

Volume	15,963,800
Average Volume	9,563,952
Open	5.26
Previous Close	5.36
Day's Range	5.26 - 5.88
52-Week Range	4.43 - 6.82
Beta	0.25
RSI	41.68
Earnings Date	Mar 30, 2026

About SHE:300239

Baotou Dongbao Bio-Tech Co.,Ltd engages in the design, research and development, production, and sale of gelatin and collagen and their derivative products in the People’s Republic of China and internationally. It offers pharmaceutical gelation, food additives gelatin, and photographic gelatin; hydrolyzed collagen, collagen peptide, fish collagen peptide, and agglomerated collagen; and private label collagen and unflavored collagen jars. The company also provides organic fertilizers, water soluble fertilizers, and compound microbial fertilizers...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1960
• Employees: 1,385
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300239

Financial Performance

In 2025, SHE:300239's revenue was 745.31 million, a decrease of -15.78% compared to the previous year's 884.93 million. Earnings were 54.34 million, a decrease of -36.80%.